An experiment of nature: genetic L-arginine deficiency and NO insufficiency.
作者信息
Loscalzo J
机构信息
Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, 700 Albany Street, W507, Boston, Massachusetts 02118, USA.
出版信息
J Clin Invest. 2001 Sep;108(5):663-4. doi: 10.1172/JCI13848.
Abstract
摘要
相似文献
1
An experiment of nature: genetic L-arginine deficiency and NO insufficiency.
J Clin Invest. 2001 Sep;108(5):663-4. doi: 10.1172/JCI13848.
2
Vascular endothelial dysfunction resulting from L-arginine deficiency in a patient with lysinuric protein intolerance.
J Clin Invest. 2001 Sep;108(5):717-24. doi: 10.1172/JCI11260.
3
Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene.
Nat Genet. 1999 Mar;21(3):293-6. doi: 10.1038/6809.
4
CAT2-mediated L-arginine transport and nitric oxide production in activated macrophages.
Biochem J. 1999 Jun 1;340 ( Pt 2)(Pt 2):549-53.
5
[Lysinuric protein intolerance: a severe hyperammonemia secondary to l-arginine deficiency (author's transl)]].
Arch Fr Pediatr. 1981 Dec;38 Suppl 1:829-35.
6
Molecular cloning, tissue distribution, and chromosomal localization of human cationic amino acid transporter 2 (HCAT2).
Genomics. 1996 Dec 1;38(2):174-8. doi: 10.1006/geno.1996.0613.
7
[From avoidance of proteins to amino acid transporter gene--a long journey of lysinuric protein intolerance].
Duodecim. 1999;115(21):2307-8.
8
Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters.
Mol Pharmacol. 2000 Jan;57(1):68-74.
9
Regulation of nitric oxide production by arginine metabolic enzymes.
Biochem Biophys Res Commun. 2000 Sep 7;275(3):715-9. doi: 10.1006/bbrc.2000.3169.
10
Is atherosclerosis an arginine deficiency disease?
J Investig Med. 1998 Oct;46(8):377-80.
引用本文的文献
1
The Association Between Concentrations of Arginine, Ornithine, Citrulline and Major Depressive Disorder: A Meta-Analysis.
Front Psychiatry. 2021 Nov 18;12:686973. doi: 10.3389/fpsyt.2021.686973. eCollection 2021.
2
Atherosclerosis Linked to Aberrant Amino Acid Metabolism and Immunosuppressive Amino Acid Catabolizing Enzymes.
Front Immunol. 2020 Sep 28;11:551758. doi: 10.3389/fimmu.2020.551758. eCollection 2020.
3
Decreased serum L-arginine and L-citrulline levels in major depression.
Psychopharmacology (Berl). 2017 Nov;234(21):3241-3247. doi: 10.1007/s00213-017-4712-8. Epub 2017 Aug 13.
4
Threshold levels of extracellular l-arginine that trigger NOS-mediated ROS/RNS production in cardiac ventricular myocytes.
Am J Physiol Cell Physiol. 2017 Feb 1;312(2):C144-C154. doi: 10.1152/ajpcell.00150.2016. Epub 2016 Nov 30.
5
Environmental origins of hypertension: phylogeny, ontogeny and epigenetics.
Hypertens Res. 2015 May;38(5):299-307. doi: 10.1038/hr.2015.7. Epub 2015 Feb 19.
6
Vascular Nitric Oxide: Formation and Function.
J Blood Med. 2010 Aug 1;2010(1):147-162. doi: 10.2147/JBM.S7000.
7
Arginase: a critical regulator of nitric oxide synthesis and vascular function.
Clin Exp Pharmacol Physiol. 2007 Sep;34(9):906-11. doi: 10.1111/j.1440-1681.2007.04638.x.
8
Nitric oxide insufficiency and atherothrombosis.
Histochem Cell Biol. 2004 Oct;122(4):353-67. doi: 10.1007/s00418-004-0675-z. Epub 2004 Aug 26.
本文引用的文献
1
Vascular endothelial dysfunction resulting from L-arginine deficiency in a patient with lysinuric protein intolerance.
J Clin Invest. 2001 Sep;108(5):717-24. doi: 10.1172/JCI11260.
2
Nitric oxide insufficiency, platelet activation, and arterial thrombosis.
Circ Res. 2001 Apr 27;88(8):756-62. doi: 10.1161/hh0801.089861.
3
Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide.
Circulation. 2000 May 9;101(18):2144-8. doi: 10.1161/01.cir.101.18.2144.
4
Reduced nitric oxide production by L-arginine deficiency in lysinuric protein intolerance exacerbates intravascular coagulation.
Metabolism. 1999 Sep;48(9):1136-40. doi: 10.1016/s0026-0495(99)90127-0.
5
Characterization of L-arginine uptake by plasma membrane vesicles isolated from cultured pulmonary artery endothelial cells.
Biochim Biophys Acta. 1998 Feb 2;1369(1):173-83. doi: 10.1016/s0005-2736(97)00191-0.
6
A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox".
J Biol Chem. 1997 Dec 12;272(50):31213-6. doi: 10.1074/jbc.272.50.31213.
7
Nitric oxide released from activated platelets inhibits platelet recruitment.
J Clin Invest. 1997 Jul 15;100(2):350-6. doi: 10.1172/JCI119540.
8
Effects of in vivo and in vitro L-arginine supplementation on healthy human vessels.
J Cardiovasc Pharmacol. 1996 Jul;28(1):158-66. doi: 10.1097/00005344-199607000-00023.
9
L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation.
Biochem Biophys Res Commun. 1988 Jun 30;153(3):1251-6. doi: 10.1016/s0006-291x(88)81362-7.
10
Macrophage and endothelial cell nitric oxide synthesis: cell-type selective inhibition by NG-aminoarginine, NG-nitroarginine and NG-methylarginine.
Biochem Biophys Res Commun. 1990 Jul 16;170(1):96-103. doi: 10.1016/0006-291x(90)91245-n.
Zotero 插件